Reversal of Human Papillomavirus-Specific T Cell Immune Suppression through TLR Agonist Treatment of Langerhans Cells Exposed to Human Papillomavirus Type 16-Reference-Cited by-同舟云学术

Reversal of Human Papillomavirus-Specific T Cell Immune Suppression through TLR Agonist Treatment of Langerhans Cells Exposed to Human Papillomavirus Type 16

Published:2009-02-20 Issue:5 Volume:182 Page:2919-2928
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Fahey Laura M.,Raff Adam B.,Da Silva Diane M.,Kast W. Martin

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference50 articles.

1. Human papillomaviruses in the pathogenesis of anogenital cancer

2. Global Cancer Statistics, 2002

3. Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions

4. Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TIME Is Ticking for Cervical Cancer;Biology;2023-06-30

2. The association of cervicovaginal Langerhans cells with clearance of human papillomavirus;Frontiers in Immunology;2022-10-12

3. Transcriptomic Profiling Reveals Cancer-Associated Fibroblasts as Potential Targets for the Prognosis and Treatment of Cervical Squamous Cell Carcinoma;2021-12-23

4. Cervicovaginal Microbiome Factors in Clearance of Human Papillomavirus Infection;Frontiers in Oncology;2021-07-28

5. Insights into the toll‐like receptors in sexually transmitted infections;Scandinavian Journal of Immunology;2020-08-27